APOGEE THERAPEUTICS I
44.02
26-十一月-24 10:39:32
15 分钟延时
股票
+0.16
+0.38%
今日范围
43.13 - 44.43
ISIN
N/A
来源
NASDAQ
-
Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024
18 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2024 Financial Results
12 11月 2024 07:00:01 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics to Participate in Upcoming November Investor Conferences
04 11月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting
16 10月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit
12 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer
09 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results
12 8月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
28 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
23 5月 2024 07:30:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
13 5月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
06 5月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
07 3月 2024 18:49:51 条件 Nasdaq GlobeNewswire
-
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
05 3月 2024 16:23:09 条件 Nasdaq GlobeNewswire
-
05 3月 2024 06:10:00 条件 Nasdaq GlobeNewswire
-
05 3月 2024 06:00:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >